Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial.

Women with pregnancies had lower adherence to 1% tenofovir vaginal gel as HIV preexposure prophylaxis in CAPRISA 004, a phase IIB randomized-controlled trial.

Antiretroviral prophylaxis may be a critical strategy to reduce periconception HIV transmission. Maximizing the benefit of periconception pharmacologic HIV risk-reduction requires an understanding of the links between pregnancy and adherence to this prevention strategy.We assessed study gel adherenc...

Full description

Bibliographic Details
Main Authors: Lynn T Matthews, Sengeziwe Sibeko, Leila E Mansoor, Nonhlanhla Yende-Zuma, David R Bangsberg, Quarraisha Abdool Karim
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3589407?pdf=render

Internet

http://europepmc.org/articles/PMC3589407?pdf=render

Similar Items